Shin Nippon Biomedical Laboratories (TSE:2395) E10: 円81.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2395 Shin Nippon Biomedical Laboratories Ltd TSE:2395
74 GF Score
Price 円1,279.00
GF Value 円1,783.15
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories E10?

Shin Nippon Biomedical Laboratories TSE:2395 -1.99% 74 E10 is 円81.99 as of Mar. 2026. GuruFocus rates TSE:2395 with a GF Score™ of 74/100 and a GF Value™ of 円1,783.15 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shin Nippon Biomedical Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was 円55.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円81.99 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shin Nippon Biomedical Laboratories's average E10 Growth Rate was 5.90% per year. During the past 3 years, the average E10 Growth Rate was 23.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shin Nippon Biomedical Laboratories was 50.70% per year. The lowest was 23.70% per year. And the median was 47.60% per year.

As of today (2026-07-20), Shin Nippon Biomedical Laboratories's current stock price is 円1279.00. Shin Nippon Biomedical Laboratories's E10 for the quarter that ended in Mar. 2026 was 円81.99. Shin Nippon Biomedical Laboratories's Shiller PE Ratio of today is 15.60.

During the past 13 years, the highest Shiller PE Ratio of Shin Nippon Biomedical Laboratories was 442.68. The lowest was 13.22. And the median was 30.18.


Shin Nippon Biomedical Laboratories  (TSE:2395) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shin Nippon Biomedical Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1279.00/81.99
=15.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shin Nippon Biomedical Laboratories was 442.68. The lowest was 13.22. And the median was 30.18.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shin Nippon Biomedical Laboratories E10 Related Terms


Shin Nippon Biomedical Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories E10 Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.10 43.35 60.34 77.43 81.99

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.43 71.89 77.77 76.57 81.99

TSE:2395 vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Shiller PE Ratio falls into.


TSE:2395
74GF Score
Shin Nippon Biomedical Laboratories Ltd TSE:2395
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shin Nippon Biomedical Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=55.15/112.7000*112.7000
=55.150

Current CPI (Mar. 2026) = 112.7000.

Shin Nippon Biomedical Laboratories Quarterly Data

per share eps CPI Adj_EPS
201606 -44.210 98.100 -50.790
201609 -26.738 98.000 -30.749
201612 26.627 98.400 30.497
201703 20.861 98.100 23.966
201706 -14.510 98.500 -16.602
201709 -25.121 98.800 -28.655
201712 -7.000 99.400 -7.937
201803 -38.781 99.200 -44.059
201806 9.250 99.200 10.509
201809 12.660 99.900 14.282
201812 15.690 99.700 17.736
201903 9.240 99.700 10.445
201906 -0.990 99.800 -1.118
201909 22.060 100.100 24.837
201912 17.490 100.500 19.613
202003 22.690 100.300 25.495
202006 15.450 99.900 17.430
202009 11.910 99.900 13.436
202012 8.105 99.300 9.199
202103 52.480 99.900 59.204
202106 43.870 99.500 49.690
202109 40.280 100.100 45.350
202112 41.897 100.100 47.171
202203 45.149 101.100 50.329
202206 46.700 101.800 51.700
202209 59.460 103.100 64.997
202212 -1.640 104.100 -1.775
202303 41.033 104.400 44.295
202306 32.980 105.200 35.331
202309 38.260 106.200 40.602
202312 19.900 106.800 20.999
202403 41.714 107.200 43.854
202406 2.930 108.200 3.052
202409 29.040 108.900 30.053
202412 45.020 110.700 45.833
202503 41.300 111.100 41.895
202506 6.250 111.700 6.306
202509 19.230 112.000 19.350
202512 29.060 113.000 28.983
202603 55.150 112.700 55.150

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of 円81.99 mean?
Shin Nippon Biomedical Laboratories (TSE:2395) has a E10 of 円81.99 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shin Nippon Biomedical Laboratories and its competitors.
Is Shin Nippon Biomedical Laboratories' E10 too high?
Shin Nippon Biomedical Laboratories' current E10 is 円81.99. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' E10 compare to TMO and DHR?
Shin Nippon Biomedical Laboratories' E10 of 円81.99 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current E10 is 円81.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories (TSE:2395) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,783.15, compared to a current price of 円1,279.00 — trading 28.3% below its estimated fair value. The current E10 is 円81.99. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (TSE:2395), the current E10 is 円81.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (TSE:2395) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of 円1,279.00 is trading 28.3% below its estimated GF Value™ of 円1,783.15. GuruFocus considers Shin Nippon Biomedical Laboratories to be Modestly Undervalued.

Key valuation signals for TSE:2395:

  • E10: 円81.99
  • GF Value™: 円1,783.15 vs. price of 円1,279.00 (28.3% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the TSE:2395 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges YB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score

Get the complete analysis for TSE:2395

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,279.00
Price
円1,783.15
GF Value